Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Northwest Biotherapeutics (NWBO) has issued an update.
After over ten years of dedicated service, Mr. Jerry Jasinowski has retired from the Board of Directors at Northwest Biotherapeutics, Inc. as of March 8, 2024. At 85 years old, his retirement is attributed to health reasons and bears no connection to any disputes over the company’s operations, policies, or practices. Northwest Biotherapeutics extends its gratitude to Mr. Jasinowski for his longstanding commitment to the Board.
See more insights into NWBO stock on TipRanks’ Stock Analysis page.